SCHEMBL24617876

SCHEMBL24617876

CC(S)c1ccc2scnc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OGA O60502 4/20 0.43
ALDH1A1 P00352 2/20 0.42
HSD17B10 Q99714 1/20 0.42
FFAR1 O14842 2/20 0.41
TRPM5 Q9NZQ8 1/20 0.36
MAPK1 P28482 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
RIPK2 O43353 4/20 0.36
RIPK3 Q9Y572 2/20 0.36
RIPK1 Q13546 1/20 0.36
HSD11B1 P28845 1/20 0.35
TRPV3 Q8NET8 1/20 0.34
KDM4E B2RXH2 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
HKDC1 Q2TB90 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
SYK P43405 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23510778 1.00 OGA (0.43) OGAALDH1A1HSD17B10FFAR1TRPM5
SCHEMBL24347730 0.86 NPC1 (0.45) OGAALDH1A1HSD17B10FFAR1SMN1; SMN2
SCHEMBL12026663 0.85 ALDH1A1 (0.45) OGAALDH1A1HSD17B10FFAR1TRPM5
SCHEMBL17541540 0.82 OGA (0.43) OGAALDH1A1HSD17B10FFAR1TRPM5
SCHEMBL30644654 0.82 OGA (0.43) OGAALDH1A1HSD17B10FFAR1TRPM5
SCHEMBL21123818 0.82 OGA (0.43) OGAALDH1A1HSD17B10FFAR1TRPM5
SCHEMBL17541608 0.82 FFAR1 (0.44) OGAALDH1A1HSD17B10FFAR1TRPM5
SCHEMBL2041345 0.82 OGA (0.43) OGAALDH1A1HSD17B10FFAR1TRPM5
Hydrochloric Acid SCHEMBL3929197 0.81 OGA (0.43) OGAALDH1A1HSD17B10FFAR1TRPM5
SCHEMBL25490381 0.79 OGA (0.42) OGAALDH1A1HSD17B10FFAR1TRPM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220220111-A1 1,8-NAPHTHYRIDINONE COMPOUNDS AND USES THEREOF NUVATION BIO OPERATING COMPANY INC (US) 2022-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220220111-A1 1,8-NAPHTHYRIDINONE COMPOUNDS AND USES THEREOF NME1, ADORA2A, GPR68 OGA 2912/4885ALDH1A1 1543/4885HSD17B10 4334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.